(ABBV) AbbVie - Performance 18.9% in 12m
ABBV performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
81.90%
#3 in Peer-Group
Rel. Strength
69.77%
#2302 in Stock-Universe
Total Return 12m
18.90%
#43 in Peer-Group
Total Return 5y
151.96%
#9 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 80.1 |
| P/E Forward | 15.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 214.68 USD |
| 52 Week Low | 158.09 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 64.77 |
| Buy/Sell Signal +-5 | -0.30 |
| Support / Resistance | Levels |
|---|---|
| Support | 190.5, 185.3, 177.3, 171.0, 160.1 |
| Resistance | 199.6 |
12m Total Return: ABBV (18.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
9.2% | 80.8% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.02% | -1.47% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
10.1% | 2.09% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.05% | 33.4% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.43% | -8.71% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
10.5% | 38.9% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
-0.15% | 37.3% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.39% | 16% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: ABBV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABBV
| Total Return (including Dividends) | ABBV | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.64% | 7.80% | 1.73% |
| 3 Months | -8.84% | -2.75% | 8.59% |
| 12 Months | 18.90% | -10.76% | 11.46% |
| 5 Years | 151.96% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | ABBV | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 91.7% | 84.2% | 69.9% |
| 3 Months | -28.7% | -2.8% | 69.3% |
| 12 Months | 35.3% | -77.8% | 43.2% |
| 5 Years | 94.6% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #132 | -5.72% | -0.09% |
| 3 Month | #115 | -6.26% | -16.05% |
| 12 Month | #43 | 33.23% | 6.67% |
| 5 Years | #7 | 209.35% | 20.49% |
FAQs
Does AbbVie (ABBV) outperform the market?
Yes,
over the last 12 months ABBV made 18.90%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.76%.
Over the last 3 months ABBV made -8.84%, while XBI made -2.75%.
Performance Comparison ABBV vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ABBV vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1% | -0.1% | 12.8% | 7% |
| US NASDAQ 100 | QQQ | 1.2% | -0.6% | 12.6% | 8% |
| German DAX 40 | DAX | 3.9% | 2.3% | -2.5% | -9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1% | 2.5% | 12.4% | 6% |
| Hongkong Hang Seng | HSI | -0.4% | -4.1% | -4% | -8% |
| India NIFTY 50 | INDA | 2.2% | 1.6% | 14.3% | 19% |
| Brasil Bovespa | EWZ | -0.9% | 2.3% | -4.3% | 11% |
ABBV vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.8% | -0.8% | 10.1% | -5% |
| Consumer Discretionary | XLY | 0.9% | 3.3% | 22% | 0% |
| Consumer Staples | XLP | 1.6% | 0.4% | 12.3% | 11% |
| Energy | XLE | -5% | -1.1% | 11.9% | 16% |
| Financial | XLF | 3.2% | 3.8% | 10.6% | -6% |
| Health Care | XLV | -0.6% | -1.6% | 14.9% | 24% |
| Industrial | XLI | 2.2% | 0.7% | 7.6% | 1% |
| Materials | XLB | 1.1% | 0.1% | 13.4% | 20% |
| Real Estate | XLRE | 0.6% | -0.3% | 12.8% | 6% |
| Technology | XLK | 0.3% | -1.2% | 11.9% | 13% |
| Utilities | XLU | 0.4% | -0.6% | 5.8% | -1% |
| Aerospace & Defense | XAR | 0.9% | -6.5% | -5.8% | -23% |
| Biotech | XBI | 1.4% | -6.2% | 22.8% | 30% |
| Homebuilder | XHB | 1.6% | 8.5% | 29.5% | 29% |
| Retail | XRT | 4.5% | 0.5% | 20.9% | 18% |
ABBV vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -11.7% | -13.6% | 4.18% | 13% |
| Natural Gas | UNG | 5.4% | 11.7% | -2.7% | 38% |
| Gold | GLD | -3% | -4% | -17.2% | -30% |
| Silver | SLV | -0.2% | -8.5% | -6.5% | -6% |
| Copper | CPER | 2.2% | 0.4% | -1.7% | 11% |
ABBV vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.5% | 0.8% | 14.4% | 23% |
| iShares High Yield Corp. Bond | HYG | 0.6% | 1.3% | 9.4% | 10% |